Creative approaches to improving access to medicines globally: Ideas from the hepatitis C experience

3 December 2019
Geneva, Switzerland

Access to medical products is a complex global challenge at the interface between health, economics, politics and development. This one-day symposium organised in collaboration with the Swiss Federal Institute of Intellectual Property and the Federal Office of Public Health focuses on a sub-set of access to medicines challenges, using Hepatitis C virus (HCV) as an extended case study to facilitate discussions and novel thinking.



Expanding national treatment programmes

Moderator: Martina Schwab, Co-head, Global Health Section, Swiss Federal Office of Public Health


  • Philip Bruggmann, Chair Swiss Hepatitis, PD Dr. med., University of Zurich
  • Heba Wanis, Researcher, Third World Network
  • Gregory Dore, Professor, Kirby Institute, University of New South Wales,
  • Datuk Dr. Noor Hisham Abdullah, Director General of Health, Ministry of Health, Malaysia, and DNDi Board Member


Evolving innovation models and implications for access

Moderator: Lucas von Wattenwyl, Senior Advisor, Federal Institute of Intellectual Property


  • Victor Roy, Research Fellow, UCL Institute for Innovation and Public Purpose
  • Rekha Ramesh, Head of Global Public Policy, Gilead Sciences
  • Ari-Pekka Laitsaari, Expert in Growth Capital and Innovation Financing at the European Investment Bank
  • Bernard Pecoul, Executive Director, Drugs for Neglected Diseases initiative, Switzerland



More information: